Nuvectra to Report Third Quarter 2017 Financial Results on November 1, 2017
October 24 2017 - 8:01AM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that it will release its financial
results for the third quarter ended September 30, 2017 on
Wednesday, November 1, 2017 after market close.
Nuvectra will hold a conference call on
Wednesday, November 1, 2017 at 4:30pm ET to discuss the results.
The dial in numbers are (844) 882-7830 for domestic callers and
(574) 990-9704 for international callers. The conference ID is
95424626. A live webcast of the conference call will be
available on the investor relations section of the Company’s
website at http://investors.nuvectramed.com/.
A replay of the call will be available starting
on November 1, 2017 through November 8, 2017. To access the replay,
dial (855) 859-2056 for domestic callers and (404) 537-3406 for
international callers and enter access code 95424626. The webcast
will be available in the investor relations section of the
Company’s website for 90 days following the completion of the
call.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company
committed to helping physicians improve the lives of people with
chronic conditions. The Algovita® Spinal Cord Stimulation (SCS)
System is our first commercial offering and is CE marked and FDA
approved for the treatment of chronic intractable pain of the trunk
and/or limbs. Our innovative technology platform also has
capabilities under development to support other indications such as
sacral neuromodulation (SNM) for the treatment of overactive
bladder, and deep brain stimulation (DBS) for the treatment of
Parkinson’s Disease. In addition, our NeuroNexus subsidiary
designs, manufactures and markets leading-edge neural-interface
technologies for the neuroscience clinical research market. Visit
the Nuvectra website at www.nuvectramed.com.
Company
Contacts:Nuvectra Corporation
Walter Berger, COO & CFO(214)
474-3102wberger@nuvectramed.com
Investor Contacts:The
Ruth Group
Zack Kubow / Brian Johnston(646) 536-7020 /
7028investors@nuvectramed.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jul 2023 to Jul 2024